MIRA INFORM REPORT

 

 

Report Date :

26.09.2013

 

IDENTIFICATION DETAILS

 

Name :

ASCENT MEDITECH LIMITED

 

 

Registered Office :

Unit No.3, Plot No.9, DamanGanga Industrial Estate, Athal, Silvassa, Dadra & Nagar Haveli, Naroli – 396230, Dadar and Nagar Haveli

 

 

Country :

India

 

 

Date of Incorporation :

12.06.2012

 

 

Com. Reg. No.:

56-000404

 

 

Capital Investment / Paid-up Capital :

Rs. 10.000 Millions

 

 

CIN No.:

[Company Identification No.]

U33110DN2012PLC000404

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Marketing of Healthcare Product

 

 

No. of Employees :

1000 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was established as a partnership concern in 1993 with name “Ascent Healthcare”. In 2012, the concern got converted into limited company with mane “Ascent Meditech Limited”.

 

Subject is an established company having a moderate track record.

 

Ms. Amrapali, Manager has provided us the general information and denied to disclose the financial information.

 

However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered normal for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term Rating = BB-

Rating Explanation

Having moderate risk of default regarding timely servicing of financial obligation  

Date

17.09.2013

 

Rating Agency Name

CRISIL

Rating

Short term Rating = A4+

Rating Explanation

Having Minimal degree of safety and carry very high credit risk and are susceptible to default

Date

17.09.2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY

 

Name :

Ms. Amrapali

Designation :

Manager

Contact No.:

91-22-28828644

Date :

25.09.2013

 

 

LOCATIONS

 

Registered Office :

Unit No.3, Plot No.9, DamanGanga Industrial Estate, Athal, Silvassa, Dadra & Nagar Haveli, Naroli – 396230, Dadar and Nagar Haveli, India

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

rajiv@ascentmeditech.com

sales@ascentmeditech.com

Website :

http://www.ascentmeditech.com

Area :

 

Location :

Owned

 

 

Branch Office :

Unit No.1101, 11th Floor, project known as Cello Triumph, I B patel road, off Western Express highway, Goregaon (East), Mumbai -  400063, Maharashtra, India

Tel. No.:

91-22-28828644

Fax No.:

91-22-28828647

 

 

DIRECTORS

 

Name :

Mr. Rajkumar Siriram Vijan

Designation :

Director

Address :

Aashiyana, Plot No. – 30, G.I.D.C. Colony, Umbergoan, Valsad – 396170, Gujarat, India 

Date of Birth/Age :

11.04.1967

Date of Appointment :

12.06.2012

DIN No.:

01137822

Other Directorship

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U50101GJ1996PTC030695

ASCENT HEALTH CARE PRIVATE LIMITED

Director

12-09-96

12-09-96

-

Active

NO

2

U36991GJ2002PTC040329

AARTI WRITING PRODUCTS PRIVATE LIMITED

Director

02-01-02

02-01-02

-

Active

NO

3

U33110DN2012PLC000404

ASCENT MEDITECH LIMITED

Director

12-06-12

12-06-12

-

Active

NO

 

 

Name :

Rajiv Ishwarbhai Mistry

Designation :

Director

Address :

Sai Kripa, Udva Road, Sanjan, Umbergaon, Valsad – 396125, Gujarat, India 

Date of Birth/Age :

13.01.1969

Date of Appointment :

12.06.2012

DIN No.:

01382798

Other Directorship

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U50101GJ1996PTC030695

ASCENT HEALTH CARE PRIVATE LIMITED

Director

01-04-97

01-04-97

-

Active

NO

2

U33110DN2012PLC000404

ASCENT MEDITECH LIMITED

Director

12-06-12

12-06-12

-

Active

NO

 

 

Name :

Ajay Gunvantrai Shah

Designation :

 

Address :

1, Amar Arcade, Buddh Society, Halar Cross Road, Valsad – 396001, Gujarat, India 

Date of Birth/Age :

23.12.1966

Date of Appointment :

12.06.2012

DIN No.:

00420389

Other Directorship

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74140MH1983PTC030638

RATHOD MANAGEMENT CONSULTANCY PRIVATE LIMITED

Whole-time director

26-08-89

26-08-89

-

Active

NO

2

U67120GJ1995PTC025297

RATHOD INVESTMENTS AND HOLDINGS PRIVATE LIMITED

Whole-time director

03-04-95

03-04-95

-

Active

NO

3

U74999MH1984PLC033835

GARTELS WERKE LIMITED

Director

02-03-98

02-03-98

-

Active

NO

4

U33110DN2012PLC000404

ASCENT MEDITECH LIMITED

Director

12-06-12

12-06-12

-

Active

NO

5

U25209GJ2013PTC074591

VERITAS COMPOSITECH PRIVATE LIMITED

Director

19-04-13

19-04-13

-

Active

NO

 

 

Name :

Mrs. Mansi Rajiv Mistry

Designation :

Director

Address :

5/C, 1304/5, Spring Lear Towers, Lokhandwala Akruli Road, Kandivali (East), Mumbai – 400101, Maharashtra, India 

Date of Birth/Age :

24.06.1974

Date of Appointment :

03.12.2012

DIN No.:

03324851

 

 

Name :

Mrs. Neeta Rajkumar Vijan

Designation :

Director

Address :

"Aashiyana" Plot No. 30, GIDC Colony, Umbergaon, Valsad- 396171, Gujarat, India 

Date of Birth/Age :

15.10.1972

Date of Appointment :

03.12.2012

DIN No.:

06538400

 

 

KEY EXECUTIVES

 

Name :

Ms. Amrapali

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 25.04.2012

 

Names of Shareholders

 

No. of Shares

Rajkumar Sriram Vijan

 

40000

Rajiv Ishwarbhai Mistry

 

40000

Ajay Gunvantrai Shah

 

2000

Mansi Rajiv Mistry

 

7000

Neeta Rajkumar Vijan

 

7000

Gajindar Sriram Vijan

 

2000

Chandanben Ishwarbhai Panchal

 

2000

Total

 

100000

 

 

As on 25.09.2012

 

Names of Allotees

 

No. of Shares Allotted

Rajiv Ishwarbhai Mistry

 

450000

Rajkumar Sriram Vijan

 

450000

Total

 

900000

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Marketing of Healthcare Product

 

 

Terms :

 

Selling :

Cash / Credit

 

 

Purchasing :

Cash / Credit

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

1000 (Approximately)

 

 

Bankers :

Bank of Baroda, Shantinath Shopping Centre, 1st Floor, S. V. Road, Malad (West), Mumbai - 400064, Maharashtra, India

Tel. No.: 91-22-28899930

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

Kapadia and Associates

Chartered Accountants

Address :

Vapi, Gujarat, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

Rs.10/- each

Rs.30.000 Millions

 

 

 

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Millions

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

Particulars

 

 

 

31.03.2012

Sales Turnover (Approximately)

 

 

410.000

 

 

 

(Partly partnership and Partly Limited Company)

 

 

“Ascent Healthcare

(Partnership Concern)

 

Particulars

 

 

 

31.03.2012

Sales Turnover (Approximately)

 

 

360.000

 

 

The above information has been parted by Ms. Amrapali

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last three years

No

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

No

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

No

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

Note:

The registered office of the company has been shifted from Sai Industrial Estate, Gala No. 1to 5, IInd Phase, 1st Floor, Plat No 5, Sur. No.678/1/3, Near Naroli Chek Po, Naroli – 396235, Dadar Nagar Haveli, India to present address w.e.f. 06.06.2013

 

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

 

Charge Holder

Address

Service Request Number (SRN)

1

10370014

20/08/2013 *

146,621,000.00

BANK OF BARODA

SHANTINATH SHOPPING CENTRE, 1ST FLOOR, S. V. ROAD, MALAD (WEST), MUMBAI, MAHARASHTRA - 400064, INDIA

B82444647

 

* Date of charge modification

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.70

UK Pound

1

Rs.100.27

Euro

1

Rs.84.46

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

NTH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

 

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.